IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

5AM Venture Management, LLC

Q2 2023 Holdings

Filed 2023-08-14 | 24 holdings | $401.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Enliven Therapeutics Inc(ELVN)COM29337E102$118.3M5,798,47529.5%
Entrada Therapeutics Inc(TRDA)COM29384C108$66.7M4,408,37916.6%
Disc Medicine Inc(IRON)COM254604101$21.7M488,4425.4%
Rallybio CorpCOM75120L100$20.5M3,630,7245.1%
VOR Biopharma IncCOM929033108$19.7M6,361,7234.9%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$18.2M357,4864.5%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$15.5M862,2863.9%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$13.8M490,0003.4%
Scpharmaceuticals Inc(SCPH)COM810648105$12.2M1,200,6473.0%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$10.5M310,2702.6%
Viking Therapeutics Inc(VKTX)COM92686J106$9.5M585,0002.4%
Cogent Biosciences Inc(COGT)COM19240Q201$9.4M790,4402.3%
Pharvaris N V(PHVS)COMN69605108$8.9M587,6002.2%
Arvinas Inc(ARVN)COM04335A105$7.9M320,0002.0%
Avidity Biosciences Inc(RNA)COM05370A108$7.4M665,5551.8%
Anaptysbio Inc(ANAB)COM032724106$7.3M357,7331.8%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$7.0M192,5001.7%
Viridian Therapeutics Inc(VRDN)COM92790C104$6.7M280,0001.7%
Spruce Biosciences IncCOM85209E109$5.1M2,364,0001.3%
Mersana Therapeutics IncCOM59045L106$4.3M1,305,0001.1%
Homology Medicines IncCOM438083107$4.0M4,535,9191.0%
Impel Pharmaceuticals IncCOM45258K109$3.7M2,884,7910.9%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$1.8M152,0220.4%
Cidara Therapeutics IncCOM171757107$1.3M1,134,5110.3%